Marc Schwabish - 10 Feb 2026 Form 4 Insider Report for Tectonic Therapeutic, Inc. (TECX)

Role
Chief Business Officer
Signature
/s/ Daniel Lochner, Attorney-in-Fact
Issuer symbol
TECX
Transactions as of
10 Feb 2026
Net transactions value
+$10,710
Form type
4
Filing time
12 Feb 2026, 16:15:08 UTC
Previous filing
10 Feb 2026
Next filing
05 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Schwabish Marc Chief Business Officer C/O TECTONIC THERAPEUTIC, INC., 490 ARSENAL WAY, SUITE 200, WATERTOWN /s/ Daniel Lochner, Attorney-in-Fact 12 Feb 2026 0002023175

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TECX Common Stock Options Exercise $10,710 +4,500 +21% $2.38 25,814 10 Feb 2026 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TECX Employee Stock Option (Right to Buy) Options Exercise -4,500 -5.2% 82,014 10 Feb 2026 Common Stock 4,500 $2.38 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option vest as to 25% of the shares on March 15, 2022 with the remainder vesting in the following 36 equal monthly installments, subject to the Reporting Person's continued service on each such vesting date.
F2 Received in exchange for a stock option to acquire 170,679 shares of Tectonic common stock pursuant to that certain merger, as more specifically described in the Reporting Person's Form 4 filed with the Securities and Exchange Commission on June 24, 2024. https://www.sec.gov/Archives/edgar/data/1681087/000141588924017972/xslF345X05/form4-06242024_080616.xml